Skip to content

VRB FARMA

Active
Private limited companyfounded 2011active for 14 yearsFrederik de Merodestraat 60, 2800 Mechelen, BelgiumKBO/BCE: BE 0841.115.209
Summary

VRB FARMA has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €349,809 and a net result of €26,274. Equity has been growing by about 16% per year since 2018. Its solvency ranks better than 75% of 22,726 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 15-11-2011 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 2 others
Establishment unit
2.204.334.797 2800 Mechelen, since 16-11-2011
Financial year end
31 December
Peppol
Reachable since 21-10-2026

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€46,476
▲ 18.1%
Turnover
≈ €230,000
estimated
Profit
€26,274
▼ 50.9%
Equity
€349,809
▲ 8.1%
Total assets
€551,620
▼ 4.9%
Filed on 30-06-2026, 31 days before the deadline
Score breakdownraises riskLiquidity: current ratio 0.16, cash €13,316, halvedSector: Retail trade (NACE 47)lowers riskSize: total assets €551,620Founded in 2011Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 60% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 88+7
equity 63.4% of total assets
Liquidity 48-5
short-term debt 18.0% · cash 2.4%
Profitability 75-5
return on assets 4.8%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1%lowest value 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.2%▲ +0.1 percentage points vs 05-2025 07-2025: 0.3%▲ +0.1 percentage points vs 06-2025 08-2025: 0.5%▲ +0.2 percentage points vs 07-2025 09-2025: 0.1%▼ -0.4 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.2%▲ +0.1 percentage points vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.4%▲ +0.2 percentage points vs 07-2026 09-2026: 0.6%▲ +0.2 percentage points vs 08-2026highest value 10-2026: 0.2%▼ -0.4 percentage points vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.16 (0.39 in 2024), below 1. Short-term debt is 18% and cash 2.4% of total assets. 36.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 76% of them on solvency, 48% on liquidity, 61% on profitability and 58% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €551,620
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Founded in 2011
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Liquidity: current ratio 0.16, cash €13,316, halved
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
25 days late
2023
20 days early
2022
4 days late
2021
10 days late
2020
16 days late
2019
11 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 2 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 92% of companies in retail tradesector median €41,216 · 22,767 companies €349,809 View
  • Positive: 8 profitable years in a rowprofit 2025: €26,274 8 years View

Comparable companies

These companies have the same main activity as VRB FARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €473,000 and €664,000, founded between 2008 and 2012.

CompanyTotal assetsGross margin
VRB FARMA Mechelen€551,620€46,476
PHARMACIE DU HORLOZ Saint-Nicolas€513,078€50,252
APOTHEEK BROEKAERT Gent€544,288€47,761
J&L PHARMA Antwerpen€664,453€54,516
Apotheek Schockaert M. Dendermonde€473,175€47,103
Farmadec Asse€554,731€45,948
APOTHEEK DOCHY Kortemark€594,954€57,339
Full comparison

Key facts about VRB FARMA

What is the company number of VRB FARMA?
The company number of VRB FARMA is 0841.115.209. The VAT number is the same number with BE in front: BE 0841.115.209.
Where is VRB FARMA based?
The registered office is at Frederik de Merodestraat 60, 2800 Mechelen.Company details
What does VRB FARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of VRB FARMA?
The legal form of VRB FARMA is Private limited company (BV).
When was VRB FARMA founded?
VRB FARMA was founded on 15-11-2011.
Is VRB FARMA still active?
Yes, VRB FARMA is an active enterprise in the KBO register.
How many employees does VRB FARMA have?
VRB FARMA had an average of 0.1 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of VRB FARMA?
The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €46,476 and 51 comparable companies (NACE 477). It probably lies between €120,000 and €400,000.
Is VRB FARMA profitable?
In financial year 2025, VRB FARMA made a profit of €26,274.
Where can I find the annual accounts of VRB FARMA?
VRB FARMA filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VRB FARMA due?
VRB FARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.